Morusin alleviates mycoplasma pneumonia via the inhibition of Wnt/β-catenin and NF-κB signaling

Morusin has been traditionally used for the treatment of Mycoplasma pneumoniae pneumonia (MPP), but the underlying mechanism remains elusive. The present study aimed to explore the mechanism by which morusin achieves efficacy on mycoplasma pneumonia. Mycoplasma pneumonia model was established in BAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cunrong, Wang, Jingjing, Chen, Jianfei, Zhou, Lili, Wang, Hui, Chen, Junnian, Xu, Zhihui, Zhu, Shuaijun, Liu, Wei, Yu, Ranjie, Lu, Junli, Luo, Haoteng, Chen, Min, Chen, Weiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616039/
https://www.ncbi.nlm.nih.gov/pubmed/31171712
http://dx.doi.org/10.1042/BSR20190190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616039/
https://www.ncbi.nlm.nih.gov/pubmed/31171712
http://dx.doi.org/10.1042/BSR20190190

Ejemplares similares